RNA in brain disease: no longer just "the messenger in the middle".
about
Genomic and epigenomic responses to chronic stress involve miRNA-mediated programmingThe RNA helicase databaseMicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expressionFrontotemporal Lobar Degeneration and MicroRNAsmiR-155 is involved in Alzheimer's disease by regulating T lymphocyte functionIdentification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexesHaptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines.Interleukin-6 expression under gravitational stress due to vibration and hypergravity in follicular thyroid cancer cells.Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.miRNA malfunction causes spinal motor neuron disease.Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease.MicroRNA in Situ Hybridization in the Human Entorhinal and Transentorhinal Cortex.The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1.Certain adenylated non-coding RNAs, including 5' leader sequences of primary microRNA transcripts, accumulate in mouse cells following depletion of the RNA helicase MTR4High-throughput experimental studies to identify miRNA targets directly, with special focus on the mammalian brain.miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative diseaseThe crystal structure of Mtr4 reveals a novel arch domain required for rRNA processingOxidative damage to RNA: mechanisms, consequences, and diseases.Epigenetic control of agingThe Mtr4 ratchet helix and arch domain both function to promote RNA unwindingTumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitroMicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brainThe influence of tumour necrosis factor- α (TNF-α) on amyloid-β (Aβ)-degrading enzymes in vitro.Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.Novel human ABCC9/SUR2 brain-expressed transcripts and an eQTL relevant to hippocampal sclerosis of agingmicroRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the BrainABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.Current and future directions in genomics of amyotrophic lateral sclerosis.New perspectives on central and peripheral immune responses to acute traumatic brain injury.The Role of MicroRNAs in Human DiseasesStudying microRNAs in the brain: technical lessons learned from the first ten years.Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels.An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells.MicroRNAs (miRNAs) in neurodegenerative diseases.A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.MicroRNA: An emerging therapeutic target and intervention toolTechnical variables in high-throughput miRNA expression profiling: much work remains to be done.Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.
P2860
Q21134921-85B07921-1A34-4564-B807-25A7D430B17FQ24616929-D36DC082-F015-4162-9918-697B9BC5E119Q24655492-B0FE7AEC-32BA-49C3-8A72-1CA76F6C6EBFQ26768177-6207756D-6327-4B82-A509-0C3BCC85636DQ28087564-D53BDD48-9AA9-4DB2-BEB9-91DF0B2C82C5Q28297716-0DE15ACD-0FA8-4B01-AFCF-FD5B4FAC94E9Q29346953-08CF09F0-F64B-4C29-A936-0396941118D5Q30352007-70B0A196-A00D-4552-8E41-25F8BC7AF23CQ30378181-FD2B1807-05FC-453E-BB3D-EE81163E883CQ30495998-D19B8421-F95C-406C-B829-A7617A537075Q31028501-9EADB660-6426-4DFB-B445-0F45692F1CF8Q33701433-D24C9251-C338-479F-AD44-5B526CA06187Q33722837-A1E66A84-46EE-40B4-960A-4D555BC144E4Q33753679-4FD58F52-6882-413C-B09B-3D7537DBDDEDQ33943476-79822C82-414D-4FDA-AA63-3A58DEFEEDB5Q33947283-DBE93B9F-0347-4B91-ADA1-68E8299B8A39Q34000158-780471E8-D051-4ADA-AFE8-65D5B20FA3C9Q34441389-1734CCAD-79D1-44C7-AB81-76BF373D61D3Q34460981-3571FC4C-CCD0-4CB6-AF90-93B7BF6CE008Q34711978-149C5635-8BE1-4EA2-B935-7673F9D7087CQ35031990-ED765642-89C8-46B8-9950-858273671193Q35181216-CD586D93-7B0D-4600-871F-7A22216F5970Q35208140-2AABC687-F271-4B81-8991-C9163CF26C94Q35625868-B5F69DF7-77C0-4EEE-B1B2-104B0EDEFFCFQ35740484-74B21CB3-4F57-45EF-9BDD-7CE6542B2E56Q36121718-0AAF4A15-C8C5-45BC-8B1C-9B49ECB843B6Q36254032-DBC08791-F69F-4743-9886-90ACBF0A9C66Q36322637-93EA9DFE-CB00-4D78-8ACE-313033DF79B2Q36473151-71BBFA63-7F5F-4DA7-BF40-CB6EF1E7CB2BQ36478408-04B36E09-47CB-4778-9109-9308AAA094E2Q36571349-F0E28BBE-69AC-4064-A00F-9F17183F91C6Q36798899-828C665F-DF96-4F45-B331-DBDF06828F60Q36891503-F39AB67B-3847-4CB0-ACEB-99DD958BABA3Q36968407-B7210A88-48B1-495B-9DD7-EA7E2CFDC19CQ37069478-7651687D-5800-4D09-81AD-313CC54DA7C1Q37122270-8A4F3C71-8693-41E0-8488-0A861AAAC915Q37135817-96478AD9-8739-41AF-912A-009D8512F690Q37148524-18B8900D-6A78-4D49-A23B-E5291D4CEEB2Q37218110-E6E674C4-A3EC-4C7E-80A8-E40C740AEA31Q37397290-979EE79D-1B17-4A36-8076-890E8398FE87
P2860
RNA in brain disease: no longer just "the messenger in the middle".
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
RNA in brain disease: no longer just "the messenger in the middle".
@en
type
label
RNA in brain disease: no longer just "the messenger in the middle".
@en
prefLabel
RNA in brain disease: no longer just "the messenger in the middle".
@en
P2860
P1476
RNA in brain disease: no longer just "the messenger in the middle"
@en
P2093
Peter T Nelson
P2860
P304
P356
10.1097/01.JNEN.0000240474.27791.F3
P50
P577
2007-06-01T00:00:00Z